Browsing: Cardiovascular

Intermittent Fasting: Weighing Health Benefits Against Potential Cardiovascular Concerns

By 1
Intermittent Fasting has been gaining in popularity. A recent study found that 10% of the American population participates in this diet. It is a caloric restriction revolving around a short window for eating and a comparatively larger window for fasting. In this article, we review the health benefits against the potential cardiovascular concerns.

Log In or Register as a healthcare professional to read the full article.

Not just weight loss – Semaglutide and Cardiovascular Benefits

By 0
With the emergence and increasing popularity of glucagon-like peptide 1 (GLP-1) agonists for the treatment of obesity in recent years, it might be worth investigating if these agents are able to reduce the cardiovascular risks associated with overweight and obesity, especially since they have been shown to reduce risk of major adverse cardiovascular events in patients with type 2 diabetes who are at high cardiovascular risk.

Log In or Register as a healthcare professional to read the full article.

When is the best time for multivessel percutaneous coronary intervention post myocardial infarction?

By 0
Summary: The recent MULTISTARS AMI trial reveals significant findings, indicating that immediate multivessel PCI is non-inferior to staged procedures for patients with STEMI and multivessel coronary artery disease. This approach potentially alters the course of treatment by reducing serious cardiac events, thereby influencing guidelines on the optimal timing for such interventions.

Log In or Register as a healthcare professional to read the full article.

Sleep Deprivation And Cardiovascular Health : A Silent Epidemic Among Malaysians

By 0

A recent study shows that delaying sleep by just 90 minutes each night damages blood vessels, contributing to the development of cardiovascular diseases. A study conducted in the University of Columbia recently showed that mild sleep restriction among female individuals causes an increase in oxidative stress in blood vessels. It is the first direct evidence linking mild, chronic sleep deficits to causing heart disease.

Intravenous Iron In Ambulant Patients With Heart Failure – Do We See The Same Benefits?

By 0
Iron deficiency is present in 50% of the patients with heart failure and it is associated with worse symptoms and outcomes [1]. There have been a few studies analysing the benefit of intravenous (IV) ferric carboxymaltose in heart failure with iron deficiency. In the AFFIRM-AHF [2] trial, administration of IV ferric carboxymaltose reduced the risk of cardiovascular death and total hospitalisations for heart failure in patients hospitalized for acute heart failure.

Log In or Register as a healthcare professional to read the full article.